Hofseth Biocare ASA (OL:HBC) — Market Cap & Net Worth
Market Cap & Net Worth: Hofseth Biocare ASA (HBC)
Hofseth Biocare ASA (OL:HBC) has a market capitalization of $55.08 Million (Nkr523.48 Million) as of May 3, 2026. Listed on the OL stock exchange, this Norway-based company holds position #21512 globally and #198 in its home market, demonstrating a 0.38% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hofseth Biocare ASA's stock price Nkr1.33 by its total outstanding shares 395075736 (395.08 Million). Analyse HBC cash flow metrics to see how efficiently the company converts income to cash.
Hofseth Biocare ASA Market Cap History: 2015 to 2026
Hofseth Biocare ASA's market capitalization history from 2015 to 2026. Data shows change from $124.72 Million to $55.08 Million (-9.22% CAGR).
Hofseth Biocare ASA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hofseth Biocare ASA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.27x
Hofseth Biocare ASA's market cap is 0.27 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $124.72 Million | $55.14 Million | -$100.19 Million | 2.26x | N/A |
| 2016 | $49.47 Million | $20.20 Million | -$147.45 Million | 2.45x | N/A |
| 2017 | $72.75 Million | $118.48 Million | -$16.48 Million | 0.61x | N/A |
| 2018 | $99.78 Million | $60.74 Million | -$84.77 Million | 1.64x | N/A |
| 2019 | $374.16 Million | $67.78 Million | -$89.21 Million | 5.52x | N/A |
| 2020 | $407.42 Million | $69.25 Million | -$102.09 Million | 5.88x | N/A |
| 2021 | $286.86 Million | $87.62 Million | -$126.46 Million | 3.27x | N/A |
| 2022 | $136.78 Million | $120.45 Million | -$137.39 Million | 1.14x | N/A |
| 2023 | $108.92 Million | $194.87 Million | -$106.68 Million | 0.56x | N/A |
| 2024 | $70.67 Million | $257.42 Million | -$123.41 Million | 0.27x | N/A |
Competitor Companies of HBC by Market Capitalization
Companies near Hofseth Biocare ASA in the global market cap rankings as of May 3, 2026.
Key companies related to Hofseth Biocare ASA by market ranking:
- Nestlé S.A (F:NESM): Ranked #84 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #98 globally with a market cap of $203.05 Billion USD ( CHF160.61 Billion CHF).
- Danone SA (PA:BN): Ranked #527 globally with a market cap of $50.25 Billion USD ( €42.98 Billion EUR).
- Danone SA (F:BSND): Ranked #622 globally with a market cap of $42.57 Billion USD ( €36.41 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Nestlé S.A | F:NESM | $224.33 Billion | €85.60 |
| #98 | Nestle S.A. | SW:NESN | $203.05 Billion | CHF79.05 |
| #527 | Danone SA | PA:BN | $50.25 Billion | €66.74 |
| #622 | Danone SA | F:BSND | $42.57 Billion | €12.70 |
Hofseth Biocare ASA Historical Marketcap From 2015 to 2026
Between 2015 and today, Hofseth Biocare ASA's market cap moved from $124.72 Million to $ 55.08 Million, with a yearly change of -9.22%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr55.08 Million | +0.38% |
| 2025 | Nkr54.88 Million | -22.35% |
| 2024 | Nkr70.67 Million | -35.11% |
| 2023 | Nkr108.92 Million | -20.36% |
| 2022 | Nkr136.78 Million | -52.32% |
| 2021 | Nkr286.86 Million | -29.59% |
| 2020 | Nkr407.42 Million | +8.89% |
| 2019 | Nkr374.16 Million | +275.00% |
| 2018 | Nkr99.78 Million | +37.14% |
| 2017 | Nkr72.75 Million | +47.06% |
| 2016 | Nkr49.47 Million | -60.33% |
| 2015 | Nkr124.72 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Hofseth Biocare ASA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $55.08 Million USD |
| MoneyControl | $55.08 Million USD |
| MarketWatch | $55.08 Million USD |
| marketcap.company | $55.08 Million USD |
| Reuters | $55.08 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hofseth Biocare ASA
Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a salmon oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are ca… Read more